Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.